Bloodwork question about ligandrol. Baseline, two months in, and the numbers moved in a direction I did not expect.
The effect size I actually noticed is roughly a third of what the write-ups imply, and it took two months to be sure.
The comparison group matters more than the compound when the outcome is something as fuzzy as focus.
Two weeks is not enough time to attribute anything to a compound unless the effect is dramatic.
The animal data is stronger than the human data and the human data is not nothing, it is just small.
Lipids move and nobody checks them, which is why SARMs have a reputation for being harmless.
Interested in the methods more than the conclusion.
What is the first thing you would read if you were starting from zero?
Stupid question: how do you know whether what is in the vial matches the label at all?
Same here.
A plausible mechanism is not an outcome, and this class is the textbook example.
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison.